Peripheral circulation enhancement

Peripheral circulation enhancement" refers to the broad physiological concept of increasing blood flow through peripheral tissues and organs, usually as a result of vasodilation (widening of small arteries and arterioles) or capillary recruitment. This outcome can be achieved via physical activity, thermal exposure, or drugs affecting vascular smooth muscle tone. Underlying molecular events may include modulation of endothelial mediators (such as nitric oxide, prostacyclin), activation or inhibition of adrenergic receptors, and regulation of vascular endothelial growth factor (VEGF) signaling for angiogenesis[1][2][3][4]. This process is not limited to a single molecular entity, but encompasses numerous pathways aimed at optimizing tissue perfusion and oxygenation, with implications for the prevention and management of various vascular diseases[1][2][3]. **Summary:** "Peripheral circulation enhancement" is a functional process, not a specific molecule, receptor, or druggable target. Thus, it is not appropriate to use as a canonical target entry; rather, pharmacological and non-pharmacological interventions act on diverse molecular targets (e.g., adrenergic receptors, nitric oxide synthase, potassium channels, VEGF receptors) to produce this physiological outcome.

Other names

Improved peripheral blood flowIncreased peripheral circulationPeripheral vasodilationEnhanced microcirculation